Comparison of the efficacy and safety of continuous CO2 laser and 1064 nm Q‐switched Nd:YAG Laser for the treatment of xanthelasma palpebrarum

International Journal of DermatologyVolume 62, Issue 3 p. e120-e122 Correspondence Comparison of the efficacy and safety of continuous CO2 laser and 1064 nm Q-switched Nd:YAG Laser for the treatment of xanthelasma palpebrarum Maria Polina Konstantinou MD, Corresponding Author Maria Polina Konstantinou MD [email protected] Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, France Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorGeorge Evangelou MD, PhD, George Evangelou MD, PhD Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorSalama Hegazy MD, Salama Hegazy MD Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorKonstantinos Krasagakis MD, PhD, Konstantinos Krasagakis MD, PhD Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorCristina Bulai-Livideanu MD, Cristina Bulai-Livideanu MD Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this author Maria Polina Konstantinou MD, Corresponding Author Maria Polina Konstantinou MD [email protected] Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, France Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorGeorge Evangelou MD, PhD, George Evangelou MD, PhD Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorSalama Hegazy MD, Salama Hegazy MD Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorKonstantinos Krasagakis MD, PhD, Konstantinos Krasagakis MD, PhD Dermatology Department, Medical School University of Crete, University General Hospital of Heraklion, Crete, GreeceSearch for more papers by this authorCristina Bulai-Livideanu MD, Cristina Bulai-Livideanu MD Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this author First published: 01 November 2022 https://doi.org/10.1111/ijd.16475 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume62, Issue3March 2023Pages e120-e122 RelatedInformation